| Dr John N Henrie, MD | |
|
5444 Green St, Murray, UT 84123-5632 | |
| (801) 262-8120 | |
| (801) 262-3897 |
| Full Name | Dr John N Henrie |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 5444 Green St, Murray, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477593556 | NPI | - | NPPES |
| D2017 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 345747-1205 (Utah) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | M-8443 (Idaho) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Alta View Hospital | Sandy, UT | Hospital |
| Riverton Hospital | Riverton, UT | Hospital |
| Cassia Regional Hospital | Burley, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
"The Peace Corps has announced a strategic partnership with the Water and Development Alliance (WADA) - a long-standing public-private partnership between the U.S. Agency for International Development (USAID) and the Coca-Cola Company (Coca-Cola) - to improve local capacity to deliver sustainable water supply, sanitation and hygiene (WASH) services for the reduction of waterborne disease around the world," a Peace Corps press release reports.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about an approach known as "three share" which helps expand health coverage by spreading health insurance premium costs among the community, the employer and the worker.
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?
› Verified 2 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
"The Peace Corps has announced a strategic partnership with the Water and Development Alliance (WADA) - a long-standing public-private partnership between the U.S. Agency for International Development (USAID) and the Coca-Cola Company (Coca-Cola) - to improve local capacity to deliver sustainable water supply, sanitation and hygiene (WASH) services for the reduction of waterborne disease around the world," a Peace Corps press release reports.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about an approach known as "three share" which helps expand health coverage by spreading health insurance premium costs among the community, the employer and the worker.
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?
› Verified 2 days ago
| Entity Name | Mountain Medical Physician Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720035520 PECOS PAC ID: 5294639407 Enrollment ID: O20031120000357 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
"The Peace Corps has announced a strategic partnership with the Water and Development Alliance (WADA) - a long-standing public-private partnership between the U.S. Agency for International Development (USAID) and the Coca-Cola Company (Coca-Cola) - to improve local capacity to deliver sustainable water supply, sanitation and hygiene (WASH) services for the reduction of waterborne disease around the world," a Peace Corps press release reports.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about an approach known as "three share" which helps expand health coverage by spreading health insurance premium costs among the community, the employer and the worker.
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?
› Verified 2 days ago
| Entity Name | Tellica Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760197198 PECOS PAC ID: 3577950765 Enrollment ID: O20231201000761 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
"The Peace Corps has announced a strategic partnership with the Water and Development Alliance (WADA) - a long-standing public-private partnership between the U.S. Agency for International Development (USAID) and the Coca-Cola Company (Coca-Cola) - to improve local capacity to deliver sustainable water supply, sanitation and hygiene (WASH) services for the reduction of waterborne disease around the world," a Peace Corps press release reports.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about an approach known as "three share" which helps expand health coverage by spreading health insurance premium costs among the community, the employer and the worker.
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John N Henrie, MD 5444 Green St, Murray, UT 84123-5632 Ph: (801) 286-2264 | Dr John N Henrie, MD 5444 Green St, Murray, UT 84123-5632 Ph: (801) 262-8120 |
News Archive
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy. SMA is a severe and rare genetic neuromuscular disease characterized by muscle atrophy and weakness and is the most common genetic cause of infant mortality.
"The Peace Corps has announced a strategic partnership with the Water and Development Alliance (WADA) - a long-standing public-private partnership between the U.S. Agency for International Development (USAID) and the Coca-Cola Company (Coca-Cola) - to improve local capacity to deliver sustainable water supply, sanitation and hygiene (WASH) services for the reduction of waterborne disease around the world," a Peace Corps press release reports.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about an approach known as "three share" which helps expand health coverage by spreading health insurance premium costs among the community, the employer and the worker.
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?
› Verified 2 days ago
Karen Anne Dittrich, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5444 S. Green St., Murray, UT 84123 Phone: 801-262-8120 Fax: 801-262-3897 | |
Dr. Jonathan Scott Shakespear, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5444 S. Green St., Murray, UT 84123 Phone: 801-262-8120 Fax: 801-262-3897 | |
Dr. Steven T Hunt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5444 Green St, Murray, UT 84123 Phone: 801-262-8120 Fax: 801-262-3572 | |
Dr. Cheryl Lynn Green, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5444 Green St, Murray, UT 84123 Phone: 801-262-2647 Fax: 801-262-3897 | |
Dr. Ivan Petrovitch, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-7000 | |
Brian Matthew Sheehan, MD Radiology Medicare: Medicare Enrolled Practice Location: 5323 S Woodrow St Ste 101, Murray, UT 84107 Phone: 801-313-7500 | |
Dr. Wendell C Johnson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5444 S. Green St., Murray, UT 84123 Phone: 801-262-2647 Fax: 801-262-3897 |